Seeking new ground

Holding All The Chips

Seeking new ground

Hyseq Inc. has joined the growing list of companies reconfiguring their businesses around drug development, as it placed its original array business into a subsidiary last week in the wake of its settlement of chip technology litigation with Affymetrix Inc.

The question for HYSQ now is how it will effectively compete in the expensive game of creating drugs with only $16.5 million in the bank at Sept. 30

Read the full 726 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE